Andere Sprachen ReWalk Robotics Ltd.

Aktien

A12BMB

IL0011331076

LFWD

Markt geschlossen - Nasdaq Andere Börsenplätze 21:59:51 10.06.2024			% 5 Tage	% 1. Jan.
4,6 ^USD	0,00 %		+0,44 %	-15,50 %

16.05.	REWALK ROBOTICS LTD. : HC Wainwright bekräftigt seine Kaufempfehlung	ZM
15.05.	Transcript : ReWalk Robotics Ltd., Q1 2024 Earnings Call, May 15, 2024

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Lifeward to Present at Sidoti Virtual Investor Conference on June 12	04.06.
Earnings Flash (LFWD) REWALK ROBOTICS (DBA LIFEWARD) Reports Q1 Adjusted Loss $-0.62, vs. Street Est of Adjusted EPS $-0.70	15.05.
Earnings Flash (LFWD) REWALK ROBOTICS (DBA LIFEWARD) Reports Q1 Revenue $5.3M, vs. Street Est of $5.6M	15.05.
ReWalk: Q1 Earnings Snapshot	15.05.
Lifeward Reports First Quarter 2024 Financial Results	15.05.
Lifeward Reports First Quarter 2024 Financial Results	15.05.
ReWalk Robotics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
ReWalk Robotics Ltd. Provides Financial Guidance for the Second Quarter and Full Year of 2024	15.05.
Lifeward to Report First Quarter Financial Results on May 15, 2024	07.05.
Lifeward Announces the Appointment of Mike Swinford to its Board of Directors	22.04.
Lifeward Announces the Appointment of Mike Swinford to its Board of Directors	19.04.
ReWalk Robotics Ltd. Appoints Mike Swinford to the Board of Directors	19.04.
Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton	12.04.
Lifeward, CMS Working to Finalize Exoskeleton Medicare Payment Rate, CEO Says	01.04.
Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate	01.04.
VA STAND Act introduced in the United States Senate	22.03.
ReWalk Robotics Set to Complete 1-for-7 Reverse Split of Ordinary Stock	13.03.
Lifeward Announces Reverse Share Split	13.03.
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy	08.03.
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered	01.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ReWalk Robotics Ltd.

Aktien

A12BMB

IL0011331076

LFWD

Andere Sprachen

Filter